There are no direct trials comparing these different forms of treatment. Each has shown reasonable efficacy as detailed in the literature below. Conventional management of acute DVT is based upon ...

First-line Rybrevant plus Lazcluze improved survival versus the current standard of care in patients with mutated advanced or ...

Researchers developed an assay kit for TAT, then conducted a retrospective analysis to determine its ability to predict VTE in patients with cervical cancer.

Traditionally, the standard initial treatment for an acute episode of VTE ... similar to that of traditional therapy in patients with DVT, but not in patients with PE. [66] Cancer patients ...

Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...

Thrombosis in women is a condition where blood clots form inside the blood vessels. This can be dangerous, and it’s something ...

A nine-month-old infant was diagnosed with a radial artery aneurysm, a rare and dangerous condition. After comprehensive ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Surviving a severe case of COVID-19 may be just as dangerous for your heart as having cardiovascular disease - even if you were perfectly healthy before infection.